Pathway enrichment analysis showed that pathways in cancer (17%), PI3K‐Akt signalling pathway (14%), proteoglycans in cancer (11%), oestrogen signalling pathway (10%) and toxoplasmosis (10%) were enriched in the KEGG pathway (Figure 3A). The gene discussed is AKT1; the disease is cancer.